Rate Shows / BiotechTV - NewsStifel's Head of Therapeutics Research Paul Matteis shares his take on biotech and discusses companies he covers that have been in the newsFrom BiotechTV - News · 11 days ago · 12 minYour browser cannot play this audio here.This plays from the publisher's own server. We do not host a copy.Open at the sourceNot rated yetNot interested: Stifel's Head of Therapeutics Research Paul Matteis shares his take on biotech and discusses companies he covers that have been in the newsClear rating for Stifel's Head of Therapeutics Research Paul Matteis shares his take on biotech and discusses companies he covers that have been in the newsSave for laterIn Library Stifel's Head of Therapeutics Research Paul Matteis shares his take on biotech and discusses companies he covers that have been in the newsDescriptionHe discusses Biogen, Alnylam, Xenon, and Compass PathwaysBack to BiotechTV - News · Report a problem